AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets Biotech Investing
Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial Cannabis Investing News
Aurinia Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Biotech Investing
Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19 Pharmaceutical Investing
Medtronic SVP of Strategy Mike Weinstein to Speak at Evercore ISI Healthcare Conference Medical Device Investing
CEO Spotlight: Portage Biotech CEO Dr. Ian Walters Talks Asset Pipeline, Uplist, and Strategic Initiatives in a $20 Billion Sector Biotech Investing
New Survey Finds Critical Need for Education on Cataracts and Modern Treatment Options Medical Device Investing
Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp. Cannabis Investing News
Gilead Canada Announces Notice of Compliance for DESCOVY® for HIV Pre-exposure Prophylaxis Biotech Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
